Yuhan & CKD smile in 3rd quarter’s performance among Big 5 pharmas
It was analyzed the Big 5 pharmaceutical companies had different performances in sales in the 3rd quarter.
While Yuhan Corporation and Chong Kun Dang(CKD) recorded decent performances, Hanmi Pharm, Green Cross and Dong-A ST are expected to have poor records.
Yuanta Securities Korea analyzed the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
